Participation of the patients throughout the cycle of the development of a drug

It is essential to imply patients in the activities throughout the process of development of a drug.

The different initiatives about patient participation in clinical trials are on the program of this symposium, with as an concrete example the current pilot projects whereby patient representatives are enroled in the evaluation of clinical trials.

 

For more information